Company Overview

ViewRay® Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdian® the world’s first MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. MRIdian addresses key limitations of existing external-beam radiation therapy technologies because it integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered. Real-time MRI-imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment allowing the system to deliver radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian’s targeting accuracy combined with improved tumor visibility and accurate dose recording means clinicians can treat patients who may not previously have been considered radiation therapy candidates. ViewRay believes MRIdian may improve the safety and efficacy of radiation therapy, potentially leading to improved patient outcomes with reduced side-effects from off-target radiation delivery.

Financial News

Date Title and Summary Additional Formats
Toggle Summary Enloe Medical Center Becomes First Community Hospital in Northern California to Purchase a MRIdian MRI-Guided Radiation Therapy System
System Order Will Bring the Benefits of MRI-guidance and On-table Adaptive Therapy to Patients Throughout the Region CLEVELAND , March 19, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Enloe Medical Center – an independent, nonprofit hospital in Chico , California– has
Toggle Summary Ludwig-Maximilians-University Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
First Treatments at Munich Hospital Leverage MRIdian's Precision for High-Dose Delivery and Adaptive Therapy Capabilities CLEVELAND , March 18, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Ludwig-Maximilians-University Hospital in Munich has begun patient treatments with
Toggle Summary ViewRay Reports Fourth Quarter and Full Year 2019 Results
CLEVELAND , March 12, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the fourth quarter and full year ended December 31, 2019 . A supplemental presentation for today's conference call is included on the Company's website at
Toggle Summary ViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2019 Financial Results to be Held After Market on March 12, 2020
CLEVELAND , Feb. 13, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2019 financial results. ViewRay will hold a conference call to discuss results on Thursday, March 12, 2020 at 4:30 p.m. ET / 1:30 p.m. PT .

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

Financial Events
More events are coming soon.

E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!
Click here for E-mail Alerts

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449
Website: www.amstock.com
Email: info@amstock.com

In Need of Customer Support? Contact

  Language Select